DOI:
10.1055/s-00000036
Laryngo-Rhino-Otologie
LinksClose Window
References
Hanania NA. et al.
Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): Replicate, phase 3, randomised, double-blind, placebo-controlled trials.
Lancet Respir Med 2016;
4: 781-796
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.